FDA Inspection 1258117 — Enrique Lara Gonzalez, MD
The FDA completed an inspection of Enrique Lara Gonzalez, MD on Dec 6, 2024 in Merida. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 6, 2024
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Merida (Mexico)
Additional Details
Clinical Investigator (CI)